Myriad to expand ad campaign for cancer gene test

Myriad Genetics' direct-to-consumer advertising for its breast-cancer-gene test generated a 55% increase in sales, and the company plans to broaden the ads' distribution later this year. Myriad said the test, which identifies BRCA1 and BRCA2 mutations, could help women live longer and healthier lives. Some critics, however, say the campaign may prompt women to take the test without seeking proper medical advice.

View Full Article in:

Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Pompano Beach, FL